PURE‑HYALSodium Hyaluronate 1.4% — Prefilled Syringe
High-purity cohesive OVD with viscosity exceeding competitors' 1.6% — engineered for superior endothelial protection, stable chamber maintenance, and precise intraocular manipulation in cataract surgery.
See PURE‑HYAL up close.
Premium packaging, SCHOTT glass syringe, and clarity-first product presentation.
1.4% that outperforms
competitors' 1.6%.
Through high molecular weight sodium hyaluronate and optimised formulation, PURE‑HYAL 1.4% delivers viscosity that exceeds many 1.6% formulations on the market — while being easier to aspirate and remove.
Lower concentration, higher performance. Better aspiration, easier removal, superior chamber maintenance.
Engineered for what surgeons
actually need.
PURE‑HYAL combines high-purity sodium hyaluronate with cohesive viscoelastic behaviour for predictable surgical performance.
Endothelial Protection
Cohesive sodium hyaluronate forms a protective coating over the corneal endothelium, reducing mechanical and ultrasonic stress during phacoemulsification.
Stable Anterior Chamber
Maintains depth and clarity during capsulorhexis, lens implantation, and IOL positioning — supporting confident surgical manipulation.
Predictable Handling
Smooth injection and efficient cohesive removal — supporting surgical rhythm without unnecessary resistance or residual fragments.
A complete viscosity ladder.
One trusted platform.
PURE‑HYAL is expanding — giving surgeons a full range of sodium hyaluronate concentrations from a single premium platform.
Key parameters at a glance.
Common questions about sodium
hyaluronate OVD and PURE‑HYAL.
Start with PURE‑HYAL.
Share your market and volumes. We will support you with product details, documentation, pricing, and a clear path to get started — including early access to upcoming 1.6%, 1.8%, and 2.0% concentrations.
PURE‑HYALSodium Hyaluronate 1.4% — Prefilled Syringe
High-purity cohesive OVD with viscosity exceeding competitors' 1.6% — engineered for superior endothelial protection, stable chamber maintenance, and precise intraocular manipulation in cataract surgery.
See PURE‑HYAL up close.
Premium packaging, SCHOTT glass syringe, and clarity-first product presentation.
1.4% that outperforms
competitors' 1.6%.
Through high molecular weight sodium hyaluronate and optimised formulation, PURE‑HYAL 1.4% delivers viscosity that exceeds many 1.6% formulations on the market — while being easier to aspirate and remove.
Lower concentration, higher performance. Better aspiration, easier removal, superior chamber maintenance.
Engineered for what surgeons
actually need.
PURE‑HYAL combines high-purity sodium hyaluronate with cohesive viscoelastic behaviour for predictable surgical performance.
Endothelial Protection
Cohesive sodium hyaluronate forms a protective coating over the corneal endothelium, reducing mechanical and ultrasonic stress during phacoemulsification.
Stable Anterior Chamber
Maintains depth and clarity during capsulorhexis, lens implantation, and IOL positioning — supporting confident surgical manipulation.
Predictable Handling
Smooth injection and efficient cohesive removal — supporting surgical rhythm without unnecessary resistance or residual fragments.
A complete viscosity ladder.
One trusted platform.
PURE‑HYAL is expanding — giving surgeons a full range of sodium hyaluronate concentrations from a single premium platform.
Key parameters at a glance.
Common questions about sodium
hyaluronate OVD and PURE‑HYAL.
Start with PURE‑HYAL.
Share your market and volumes. We will support you with product details, documentation, pricing, and a clear path to get started — including early access to upcoming 1.6%, 1.8%, and 2.0% concentrations.
